Warburg, Pincus Equity sells stake in ZymoGenetics through secondry offering - MarketLine Financial Deals

Warburg, Pincus Equity sells stake in ZymoGenetics through secondry offering

Warburg, Pincus Equity sells stake in ZymoGenetics through secondry offering - MarketLine Financial Deals
Warburg, Pincus Equity sells stake in ZymoGenetics through secondry offering
Published Nov 25, 2008
2 pages — Published Nov 25, 2008
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

Warburg, Pincus Equity Partners, L.P., a private equity fund managed by Warburg Pincus LLC, and its affiliates, is planning to sell, through a secondary offering, a 13.7% stake, in ZymoGenetics, Inc., a US-based developer and manufacturer of therapeutic proteins.

  
Source:
Document ID
MA00674_081127
Country
Ticker
ZGEN=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Warburg, Pincus Equity sells stake in ZymoGenetics through secondry offering" Nov 25, 2008. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Warburg-Pincus-Equity-sells-stake-in-ZymoGenetics-through-secondry-offering-2052-615>
  
APA:
MarketLine Financial Deals. (2008). Warburg, Pincus Equity sells stake in ZymoGenetics through secondry offering Nov 25, 2008. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Warburg-Pincus-Equity-sells-stake-in-ZymoGenetics-through-secondry-offering-2052-615>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.